Thase ME
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
ArticlePsychedelics
Blinding Integrity and Psychedelic Drug Trials-Reply.
ArticleKetamine
Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.
Article5-MeO-DMT
GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
ArticleDMT
GH001 Efficacy is Independent of Prior Antidepressant Treatment Failures in Treatment-Resistant Depression: A Post Hoc Analysis of a Phase 2b Randomized Controlled Trial.
ArticleKetamine
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial.
ArticleKetamine
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide.
ArticleKetamine
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol.
ArticlePsilocybin
Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.
ArticleKetamine